PCR Fluorescence
-
Chlamydia trachomatis, Ureaplasma Urealyticum na Neisseria Gonorrheae Nucleic Acid.
Ngwa a dabara adaba maka nchọpụta qualitative nke nje na-efe efe na-arịa ọrịa urogenital in vitro, gụnyere Chlamydia trachomatis (CT), Ureaplasma urealyticum (UU), na Neisseria gonorrhoeae (NG).
-
Herpes Simplex Nje Virus Ụdị 2 Nucleic Acid
A na-eji ngwa a maka nchọpụta qualitative nke herpes simplex virus ụdị 2 nucleic acid na nwoke urethral swab na nwanyị cervical swab sample.
-
Chlamydia Trachomatis Nucleic Acid
A na-eji ngwa a maka nchọpụta qualitative nke Chlamydia trachomatis nucleic acid na mmamịrị nwoke, swab swab nwoke na nwanyị cervical swab sample.
-
Enterovirus Universal, EV71 na CoxA16 Nucleic Acid
A na-eji ngwa a maka nchọpụta qualitative in vitro nke enterovirus, EV71 na CoxA16 nucleic acid na akpịrị swabs na mmiri mmiri herpes nke ndị ọrịa nwere ọrịa ọnụ ụkwụ ọnụ, ma na-enye ụzọ inyeaka maka nyocha nke ndị ọrịa nwere ọnụ ụkwụ ụkwụ. ọrịa.
-
Mycobacterium ụkwara nta INH na-eguzogide
A na-eji ngwa a iji qualitatively chọpụta mkpụrụ ndụ ihe nketa nke 315th amino acid nke katG gene (K315G>C) na mkpụrụ ndụ ihe nketa nke mpaghara nkwalite nke mkpụrụ ndụ InhA (- 15 C>T).
-
Ụdị isii nke ọrịa iku ume
Enwere ike iji ngwa a chọpụta nucleic acid nke SARS-CoV-2, nje influenza A, nje influenza B, adenovirus, mycoplasma pneumoniae na nje syncytial respiratory in vitro.
-
Otu B Streptococcus Nucleic Acid
A na-eji ngwa a qualitatively chọpụta otu B streptococcus nucleic acid DNA in vitro rectal swabs, vaginal swabs ma ọ bụ rectal / ikpu agwakọta swabs nke ndị inyom dị ime nwere nnukwu ihe ize ndụ gburugburu 35 ~ 37 izu nke ime, na ndị ọzọ gestational izu nwere mgbaàmà ụlọ ọgwụ dị otú ahụ. dị ka mgbawa nke membranes, egwu ime nwa oge, wdg.
-
AdV Universal na Ụdị 41 Nucleic Acid
A na-eji ngwa a maka nchọpụta qualitative in vitro nke adenovirus nucleic acid na nasopharyngeal swabs, akpịrị swabs na stool samples.
-
Mycobacterium ụkwara nta DNA
Ọ dabara maka nchọpụta qualitative nke Mycobacterium ụkwara nta DNA n'ime ihe atụ sputum ụlọ ọgwụ mmadụ, ọ dịkwa mma maka nchọpụta inyeaka nke ọrịa ụkwara nta Mycobacterium.
-
14 HPV nwere ihe ize ndụ dị elu nwere 16/18 Genotyping
A na-eji ngwa ahụ maka nchọpụta PCR nke dabeere na fluorescence qualitative nke nucleic acid irighiri ụdị papillomavirus mmadụ 14 (HPV 14, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) na cell exfoliated cervical na ụmụ nwanyị, yana maka HPV 16/18 genotyping iji nyere aka chọpụta na ịgwọ ọrịa HPV.
-
SARS-CoV-2 influenza A influenza B Nucleic Acid jikọtara
Ngwa a dabara maka nchọpụta in vitro qualitative nke SARS-CoV-2, influenza A na influenza B nucleic acid nke nasopharyngeal swab na oropharyngeal swab sample nke ndị mmadụ chere na ha bu ọrịa SARS-CoV-2, influenza A na influenza. B.
-
SARS-CoV-2 dị iche iche
Ezubere ngwa a ka ọ bụrụ nchọpụta qualitative in vitro nke novel coronavirus (SARS-CoV-2) n'ụdị imi nasopharyngeal na oropharyngeal swab.A na-achọpụta RNA sitere na SARS-CoV-2 n'ụdị iku ume n'oge nnukwu ọrịa ma ọ bụ ndị asymptomatic.Enwere ike iji ya n'ihu nchọpụta qualitative na ọdịiche nke Alfa, Beta, Gamma, Delta na Omicron.
